Impax Asset Management Group PLC Gilead Sciences, Inc. Transaction History
Impax Asset Management Group PLC
- $15.6 Billion
- Q2 2025
A detailed history of Impax Asset Management Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 294,613 shares of GILD stock, worth $36.6 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
294,613
Previous 284,006
3.73%
Holding current value
$36.6 Million
Previous $31.8 Million
2.64%
% of portfolio
0.21%
Previous 0.21%
Shares
24 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...